Catalyst Wire Dossier Catalyst Wire Dossier

ALVAIZ

eltrombopag · Teva Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALVAIZ, covering 2023-11-29 to 2026-01-15. Get the full timeline:

Most recent: FDA Approved: ALVAIZ — Supplemental Application (Teva Pharmaceuticals, Inc.)

See pricing